Performance of GEDI space-borne LiDAR for quantifying structural variation in the temperate forests of South-Eastern Australia

Monitoring forest structural properties is critical for a range of applications because structure is key to understanding and quantifying forest biophysical functioning, including stand dynamics, evapotranspiration, habitat, and recovery from disturbances. Monitoring of forest structural properties at desirable frequencies and cost globally is enabled by space-borne LiDAR missions such as the global ecosystem dynamics investigation (GEDI) mission. This study assessed the accuracy of GEDI estimates for canopy height, total plant area index (PAI), and vertical profile of plant area volume density (PAVD) and elevation over a gradient of canopy height and terrain slope, compared to estimates derived from airborne laser scanning (ALS) across two forest age-classes in the Central Highlands region of south-eastern Australia. ALS was used as a reference dataset for validation of GEDI (Version 2) dataset. Canopy height and total PAI analyses were carried out at the landscape level to understand the influence of beam-type, height of the canopy, and terrain slope. An assessment of GEDI’s terrain elevation accuracy was also carried out at the landscape level. The PAVD profile evaluation was carried out using footprints grouped into two forest age-classes, based on the areas of mountain ash (Eucalyptus regnans) forest burnt in the Central Highlands during the 1939 and 2009 wildfires. The results indicate that although GEDI is found to significantly under-estimate the total PAI and slightly over-estimate the canopy height, the GEDI estimates of canopy height and the vertical PAVD profile (above 25 m) show a good level of accuracy. Both beam-types had comparable accuracies, with increasing slope having a slightly detrimental effect on accuracy. The elevation accuracy of GEDI found the RMSE to be 10.58 m and bias to be 1.28 m, with an R2 of 1.00. The results showed GEDI is suitable for canopy densities and height in complex forests of south-eastern Australia

Tick-, Mosquito-, and Rodent-Borne Parasite Sampling Designs for the National Ecological Observatory Network [Special Feature: NEON Design]

Parasites and pathogens are increasingly recognized as significant drivers of ecological and evolutionary change in natural ecosystems. Concurrently, transmission of infectious agents among human, livestock, and wildlife populations represents a growing threat to veterinary and human health. In light of these trends and the scarcity of long-term time series data on infection rates among vectors and reservoirs, the National Ecological Observatory Network (NEON) will collect measurements and samples of a suite of tick-, mosquito-, and rodent-borne parasites through a continental-scale surveillance program. Here, we describe the sampling designs for these efforts, highlighting sampling priorities, field and analytical methods, and the data as well as archived samples to be made available to the research community. Insights generated by this sampling will advance current understanding of and ability to predict changes in infection and disease dynamics in novel, interdisciplinary, and collaborative ways

Cryptic Disc Structures Resembling Ediacaran Discoidal Fossils from the Lower Silurian Hellefjord Schist, Arctic Norway

The Hellefjord Schist, a volcaniclastic psammite-pelite formation in the Caledonides of Arctic Norway contains discoidal impressions and apparent tube casts that share morphological and taphonomic similarities to Neoproterozoic stem-holdfast forms. U-Pb zircon geochronology on the host metasediment indicates it was deposited between 437 ± 2 and 439 ± 3 Ma, but also indicates that an inferred basal conglomerate to this formation must be part of an older stratigraphic element, as it is cross-cut by a 546 ± 4 Ma pegmatite. These results confirm that the Hellefjord Schist is separated from underlying older Proterozoic rocks by a thrust. It has previously been argued that the Cambrian Substrate Revolution destroyed the ecological niches that the Neoproterozoic frond-holdfasts organisms occupied. However, the discovery of these fossils in Silurian rocks demonstrates that the environment and substrate must have been similar enough to Neoproterozoic settings that frond-holdfast bodyplans were still ecologically viable some hundred million years later

Prognostic model to predict postoperative acute kidney injury in patients undergoing major gastrointestinal surgery based on a national prospective observational cohort study.

Background: Acute illness, existing co-morbidities and surgical stress response can all contribute to postoperative acute kidney injury (AKI) in patients undergoing major gastrointestinal surgery. The aim of this study was prospectively to develop a pragmatic prognostic model to stratify patients according to risk of developing AKI after major gastrointestinal surgery. Methods: This prospective multicentre cohort study included consecutive adults undergoing elective or emergency gastrointestinal resection, liver resection or stoma reversal in 2-week blocks over a continuous 3-month period. The primary outcome was the rate of AKI within 7 days of surgery. Bootstrap stability was used to select clinically plausible risk factors into the model. Internal model validation was carried out by bootstrap validation. Results: A total of 4544 patients were included across 173 centres in the UK and Ireland. The overall rate of AKI was 14·2 per cent (646 of 4544) and the 30-day mortality rate was 1·8 per cent (84 of 4544). Stage 1 AKI was significantly associated with 30-day mortality (unadjusted odds ratio 7·61, 95 per cent c.i. 4·49 to 12·90; P < 0·001), with increasing odds of death with each AKI stage. Six variables were selected for inclusion in the prognostic model: age, sex, ASA grade, preoperative estimated glomerular filtration rate, planned open surgery and preoperative use of either an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. Internal validation demonstrated good model discrimination (c-statistic 0·65). Discussion: Following major gastrointestinal surgery, AKI occurred in one in seven patients. This preoperative prognostic model identified patients at high risk of postoperative AKI. Validation in an independent data set is required to ensure generalizability

Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Background The efficacy and safety of opicapone, a once-daily catechol-O-methyltransferase inhibitor, have been established in two large randomized, placebo-controlled, multinational pivotal trials. Still, clinical evidence from routine practice is needed to complement the data from the pivotal trials. Methods OPTIPARK (NCT02847442) was a prospective, open-label, single-arm trial conducted in Germany and the UK under clinical practice conditions. Patients with Parkinson’s disease and motor fluctuations were treated with opicapone 50 mg for 3 (Germany) or 6 (UK) months in addition to their current levodopa and other antiparkinsonian treatments. The primary endpoint was the Clinician’s Global Impression of Change (CGI-C) after 3 months. Secondary assessments included Patient Global Impressions of Change (PGI-C), the Unified Parkinson’s Disease Rating Scale (UPDRS), Parkinson’s Disease Questionnaire (PDQ-8), and the Non-Motor Symptoms Scale (NMSS). Safety assessments included evaluation of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs). Results Of the 506 patients enrolled, 495 (97.8%) took at least one dose of opicapone. Of these, 393 (79.4%) patients completed 3 months of treatment. Overall, 71.3 and 76.9% of patients experienced any improvement on CGI-C and PGI-C after 3 months, respectively (full analysis set). At 6 months, for UK subgroup only (n = 95), 85.3% of patients were judged by investigators as improved since commencing treatment. UPDRS scores at 3 months showed statistically significant improvements in activities of daily living during OFF (mean ± SD change from baseline: − 3.0 ± 4.6, p < 0.0001) and motor scores during ON (− 4.6 ± 8.1, p < 0.0001). The mean ± SD improvements of − 3.4 ± 12.8 points for PDQ-8 and -6.8 ± 19.7 points for NMSS were statistically significant versus baseline (both p < 0.0001). Most of TEAEs (94.8% of events) were of mild or moderate intensity. TEAEs considered to be at least possibly related to opicapone were reported for 45.1% of patients, with dyskinesia (11.5%) and dry mouth (6.5%) being the most frequently reported. Serious TEAEs considered at least possibly related to opicapone were reported for 1.4% of patients. Conclusions Opicapone 50 mg was effective and generally well-tolerated in PD patients with motor fluctuations treated in clinical practice. Trial registration Registered in July 2016 at clinicaltrials.gov (NCT02847442)

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Performance of GEDI Space-Borne LiDAR for Quantifying Structural Variation in the Temperate Forests of South-Eastern Australia

Monitoring forest structural properties is critical for a range of applications because structure is key to understanding and quantifying forest biophysical functioning, including stand dynamics, evapotranspiration, habitat, and recovery from disturbances. Monitoring of forest structural properties at desirable frequencies and cost globally is enabled by space-borne LiDAR missions such as the global ecosystem dynamics investigation (GEDI) mission. This study assessed the accuracy of GEDI estimates for canopy height, total plant area index (PAI), and vertical profile of plant area volume density (PAVD) and elevation over a gradient of canopy height and terrain slope, compared to estimates derived from airborne laser scanning (ALS) across two forest age-classes in the Central Highlands region of south-eastern Australia. ALS was used as a reference dataset for validation of GEDI (Version 2) dataset. Canopy height and total PAI analyses were carried out at the landscape level to understand the influence of beam-type, height of the canopy, and terrain slope. An assessment of GEDI&rsquo;s terrain elevation accuracy was also carried out at the landscape level. The PAVD profile evaluation was carried out using footprints grouped into two forest age-classes, based on the areas of mountain ash (Eucalyptus regnans) forest burnt in the Central Highlands during the 1939 and 2009 wildfires. The results indicate that although GEDI is found to significantly under-estimate the total PAI and slightly over-estimate the canopy height, the GEDI estimates of canopy height and the vertical PAVD profile (above 25 m) show a good level of accuracy. Both beam-types had comparable accuracies, with increasing slope having a slightly detrimental effect on accuracy. The elevation accuracy of GEDI found the RMSE to be 10.58 m and bias to be 1.28 m, with an R2 of 1.00. The results showed GEDI is suitable for canopy densities and height in complex forests of south-eastern Australia